Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Tjalf Ziemssen; Ovidiu A Bajenaru; Adriana Carrá; Nina de Klippel; João Correia de Sá; Astrid Edland; Jette L Frederiksen; Olivier Heinzlef; Klimentini E Karageorgiou; Rafael H Lander Delgado; Anne-Marie Landtblom; Miguel A Macías Islas; Niall Tubridy; Yossi Gilgun-Sherki

doi:10.1007/s00415-014-7565-7

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Tjalf Ziemssen, Ovidiu A Bajenaru, Adriana Carrá, Nina de Klippel, João Correia de Sá, Astrid Edland, Jette L Frederiksen, Olivier Heinzlef, Klimentini E Karageorgiou, Rafael H Lander Delgado, Anne-Marie Landtblom, Miguel A Macías Islas, Niall Tubridy, Yossi Gilgun-Sherki

Department of Neurology

Original language	English
Publication date	Jan 2015
Volume	262
DOIs	https://doi.org/10.1007/s00415-014-7565-7
Publication status	Published - Jan 2015

Series	Journal of Neurology
ISSN	0340-5354

Access to Document

10.1007/s00415-014-7565-7

Cite this

Ziemssen, T., Bajenaru, O. A., Carrá, A., de Klippel, N., Correia de Sá, J., Edland, A., Frederiksen, J. L., Heinzlef, O., Karageorgiou, K. E., Lander Delgado, R. H., Landtblom, A.-M., Macías Islas, M. A., Tubridy, N., & Gilgun-Sherki, Y. (2015, Jan). Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial. Journal of Neurology https://doi.org/10.1007/s00415-014-7565-7

Ziemssen, T, Bajenaru, OA, Carrá, A, de Klippel, N, Correia de Sá, J, Edland, A, Frederiksen, JL, Heinzlef, O, Karageorgiou, KE, Lander Delgado, RH, Landtblom, A-M, Macías Islas, MA, Tubridy, N & Gilgun-Sherki, Y 2015, Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.. https://doi.org/10.1007/s00415-014-7565-7

@misc{d1cb8b8449ad451b8d277553e7d57790,

title = "Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial",

author = "Tjalf Ziemssen and Bajenaru, \{Ovidiu A\} and Adriana Carr{\'a} and \{de Klippel\}, Nina and \{Correia de S{\'a}\}, Jo{\~a}o and Astrid Edland and Frederiksen, \{Jette L\} and Olivier Heinzlef and Karageorgiou, \{Klimentini E\} and \{Lander Delgado\}, \{Rafael H\} and Anne-Marie Landtblom and \{Mac{\'i}as Islas\}, \{Miguel A\} and Niall Tubridy and Yossi Gilgun-Sherki",

year = "2015",

month = jan,

doi = "10.1007/s00415-014-7565-7",

language = "English",

volume = "262",

series = "Journal of Neurology",

publisher = "Springer Science and Business Media Deutschland GmbH",

type = "Other",

}

TY - GEN

T1 - Erratum to

T2 - A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

AU - Ziemssen, Tjalf

AU - Bajenaru, Ovidiu A

AU - Carrá, Adriana

AU - de Klippel, Nina

AU - Correia de Sá, João

AU - Edland, Astrid

AU - Frederiksen, Jette L

AU - Heinzlef, Olivier

AU - Karageorgiou, Klimentini E

AU - Lander Delgado, Rafael H

AU - Landtblom, Anne-Marie

AU - Macías Islas, Miguel A

AU - Tubridy, Niall

AU - Gilgun-Sherki, Yossi

PY - 2015/1

Y1 - 2015/1

UR - https://www.scopus.com/pages/publications/84957940498

U2 - 10.1007/s00415-014-7565-7

DO - 10.1007/s00415-014-7565-7

M3 - Other contribution

C2 - 25417969

VL - 262

T3 - Journal of Neurology

ER -

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Access to Document

Other files and links

Cite this